Nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic Breast cancer: Results from the tnAcity trial

  1. Yardley, D.A.
  2. Coleman, R.
  3. Conte, P.
  4. Cortes, J.
  5. Brufsky, A.
  6. Shtivelband, M.
  7. Young, R.
  8. Bengala, C.
  9. Ali, H.
  10. Eakel, J.
  11. Schneeweiss, A.
  12. De La Cruz-Merino, L.
  13. Wilks, S.
  14. O’Shaughnessy, J.
  15. Glück, S.
  16. Li, H.
  17. Miller, J.
  18. Barton, D.
  19. Harbeck, N.
Aldizkaria:
Annals of Oncology

ISSN: 1569-8041,  0923-7534

Argitalpen urtea: 2018

Alea: 29

Zenbakia: 8

Orrialdeak: 1763-1770

Mota: Artikulua

DOI: 10.1093/ANNONC/MDY201 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus